RXST RXSIGHT INC

RxSight, Inc. to Present at the Piper Sandler Healthcare Conference

RxSight, Inc. to Present at the Piper Sandler Healthcare Conference

ALISO VIEJO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – November 20, 2025 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Piper Sandler 37th Annual Healthcare Conference in New York City.

RxSight’s management is scheduled to present on Wednesday, December 3, 2025, at 12:00 p.m. Eastern Time. A live and archived webcast of the presentation will be available at: .

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at .

Company Contact:

Shelley B. Thunen

Chief Financial Officer

Investor Relations Contact:

Oliver Moravcevic

VP, Investor Relations



EN
20/11/2025

Underlying

RXSTRXSIGHT INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on RXSIGHT INC

 PRESS RELEASE
Free
RXST RXSIGHT INC

RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New...

RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced certain preliminary unaudited financial and operational results for the fourth quarter and full-year 2025. In addition, the company provided an update on the previously announced Chief Financial Officer transition. Preliminary Unaudited Fourth Quarter and Full-yea...

12h / 43m 1 EN
 PRESS RELEASE
Free
RXST RXSIGHT INC

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference ALISO VIEJO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference. RxSight’s management is scheduled to present on Tuesday, January 13, 2026, at 3:45 p.m. Pacific Time / 6:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: . About RxSight, Inc. RxSigh...

January 2, 2026 1 EN
 PRESS RELEASE
Free
RXST RXSIGHT INC

RxSight, Inc. Announces Chief Financial Officer Transition

RxSight, Inc. Announces Chief Financial Officer Transition ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that Shelley Thunen, the Company’s Chief Financial Officer, is transitioning from her role. Ms. Thunen will remain with the Company until the sooner of the appointment of her successor or January 31, 2026. Ms. Thunen has agreed to support the Company as a consultant subsequent to the transition. “Shelley has been a k...

December 22, 2025 1 EN
 PRESS RELEASE
Free
RXST RXSIGHT INC

RxSight, Inc. to Present at the Piper Sandler Healthcare Conference

RxSight, Inc. to Present at the Piper Sandler Healthcare Conference ALISO VIEJO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – November 20, 2025 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Piper Sandler 37th Annual Healthcare Conference in New York City. RxSight’s management is scheduled to present on Wednesday, December 3, 2025, at 12:00 p.m. Eastern Time. A live and archived webcast of the presentation will be availabl...

November 20, 2025 1 EN
 PRESS RELEASE
Free
RXST RXSIGHT INC

RxSight, Inc. Reports Third Quarter 2025 Financial Results

RxSight, Inc. Reports Third Quarter 2025 Financial Results ALISO VIEJO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended September 30, 2025. Key Financial Highlights Reported third quarter 2025 revenue of $30.3 million, representing a decrease of 14% compared to the third quarter of 2024, reflecting: The sale of 26,045 Light Adjustable Lenses (LAL®/LAL+®), representing a 6% ...

November 5, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch